Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma

2014

Background The prognosis of diffuse intrinsic pontine glioma (DIPG) remains poor, with no drug proven to be effective.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

29

References

34

Citations